NIH-funded research R01 grant

A new wound dressing to help diabetic wounds heal faster

Official title: Engineering the open porous nanofibrous microsphere integrated fibrillar hydrogel for the co-delivery of antibacterial and angiogenic agents aimed at the rapid diabetic wound repair

Funded at Terasaki Institute for Biomedical Innovation · NIH-11115753 · Data updated 2026-11-12

This project is developing a special wound dressing that combines different materials to deliver medicines, helping diabetic wounds close quickly and prevent infection.

More Wound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTerasaki Institute for Biomedical Innovation
NIH-funded
Lab location1 site (Woodland Hills, UNITED STATES)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2025
Award (this year)$476,918
NIH project number5R01DK134903-03
Project IDNIH-11115753 on NIH RePORTER

Who could benefit from this research

Could help

This research is ultimately aimed at patients with diabetic wounds that are slow to heal or prone to infection.

Less likely to help

Patients without diabetic wounds or those with wounds not caused by diabetes may not directly benefit from this specific wound dressing.

What this research studies

We are creating a unique wound dressing made of tiny, porous spheres and a gel that responds to the body. This dressing is designed to encourage cells to move into the wound and form new tissue, which is key for fast healing. It will also release antibacterial agents to fight infection and other helpful substances to promote blood vessel growth. Our goal is to create a moist environment that supports healing and continuously delivers important medicines right where they are needed.

Why it matters

Potential benefit: If successful, this new wound dressing could significantly speed up the healing of diabetic wounds, reduce the risk of infection, and potentially prevent severe complications like amputation.

How similar studies have gone: Previous work has shown that porous nanofiber structures greatly improve cell migration and tissue integration, inspiring this novel, multi-component approach.

Where this research is happening

  • Terasaki Institute for Biomedical Innovation
    Woodland Hills, United States
    Active

Researchers

  • Principal investigator: Vitharikunnil John, Johnson — Terasaki Institute for Biomedical Innovation
  • Study coordinator: Vitharikunnil John, Johnson

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.